阿片类药物使用障碍和大脑健康:观察和遗传关联
medRxiv : the preprint server for health sciences
|January 7, 2025
概括
阿片类药物使用障碍 (OUD) 可能因果关系影响痴呆风险,特别是阿尔茨海默氏症和血管痴呆症. 与μ-阿片类受体的遗传联系表明这些长期大脑健康影响的生物学途径.
科学领域:
- 神经科学是一个神经科学.
- 公共卫生 公共卫生
- 遗传学 遗传学 是一个
背景情况:
- 阿片类药物使用障碍 (OUD) 对大脑健康的长期影响尚未得到充分研究.
- OUD对公共健康构成重大挑战,需要了解其神经系统后果.
研究的目的:
- 调查OUD对痴呆症,中风和大脑结构的潜在因果影响.
- 探索遗传倾向和阿片类受体通路在OUD相关大脑健康结果中的作用.
主要方法:
- 综合观察分析 (美国百万退伍军人计划) 和两个样本的孟德尔随机化 (MR).
- 用考克斯的比例危险模型来观察数据和MR来评估遗传关联.
- 使用cis-MR,贝叶斯定位和多基因风险得分来研究病因路径.
主要成果:
- 在观察性分析中,OUD与所有原因,阿尔茨海默氏症和血管痴呆症的风险增加有关.
- 基因代理的OUD显示与更高的痴呆风险有显著的关联 (OR=1.77).
- 微型阿片类受体基因的变异与痴呆风险密切相关;没有发现显著的大脑结构变化.
结论:
- 研究结果表明,OUD和痴呆症之间存在潜在的因果关系.
- 遗传证据支持μ-阿片类受体通路参与OUD对大脑健康的影响.
- 建议进行进一步的研究和药物监测,以了解阿片类药物对大脑的长期影响.
更多相关视频
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
5.2K
07:30Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
6.4K
相关概念视频
Human Genetics
464
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
464
Drug Abuse and Addiction: Pharmacological Phenomena
393
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
393
Substance Use Disorders Affecting Sleep
144
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
144
Opioid Receptors: Overview
302
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
302
Analgesia and Pain Management
387
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
387
Biological Causes of Schizophrenia
18
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
18
